Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	-53.36	712.22	-1527.15
Graham Fair Price	-62.11	1.95	5.13
PEG	20212.15	-27.07	0.13
Price/Book	0.97	6.57	6.51
Price/Cash Flow	-58.98	-87.78	-55.21
Prices/Earnings	604.61	181.33	-25.73
Price/Sales	-63.41	37.65	102.88
Price/FCF	-58.98	-87.78	-55.21
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	5720.45	0.07	< 0.005
Operating Margin	-95.75	0.05	-1.29
ROA	-85.88	< 0.005	-0.06
ROE	-0.06	< 0.005	-85.67
ROIC	-0.06	< 0.005	-85.73
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	-0.38	-0.48	21.31
Dividends QOQ	-0.19	-0.99	-426.18
EBIT QOQ	-2.06	-0.24	88.29
EPS QOQ	-1.93	-0.07	96.53
FCF QOQ	-5.56	-2.48	55.35
Revenue QOQ	-0.63	< 0.005	99.41
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	464.21	226.03	-51.31
Days Sales Outstanding (DSO)	257.60	92.33	-64.16
Inventory Turnover	0.19	0.40	105.37
Debt/Capitalization	0.03	0.02	-18.61
Quick Ratio	6.69	5.55	-17.04
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	4.31	4.47	3.91
Cash	1.28	1.18	-7.99
Capex	-0.03	0.01	-68.18
Free Cash Flow	-0.51	-0.32	36.43
Revenue	0.27	0.75	176.19
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	12.17	10.19	-16.25
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	66.02	-28.35	-57.05
Naive Interpretation	Member

06 - Financial Health · Bad

Rating